ArticleJournal of experimental & clinical cancer research : CR2021

Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer.

Laura Díaz-Gil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.